The First Affiliated Hospital of Foshan Trials

The First Affiliated Hospital of Foshan	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Liu, Jian Xiong

ELEGANT, NCT06385093: A Study on the Prevention and Treatment of GIOP With Eldecalcitol

Not yet recruiting

314

RoW

Eldecalcitol capsules, Edirol, Alfacalcidol tablets, Calcium carbonate tablets

Chinese SLE Treatment And Research Group, Beijing Life oasis public service center

Rheumatoid Arthritis, Osteoporosis, Osteopenia

12/25

03/26

NCT05433480: A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer

Active, not recruiting

274

RoW

BPI-16350, placebo, Fulvestrant

Betta Pharmaceuticals Co., Ltd.

Breast Cancer

12/23

07/25

NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Recruiting

12500

Europe, Canada, Japan, US, RoW

Lepodisiran Sodium, LY3819469, Placebo

Eli Lilly and Company

Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)

03/29

EMBER-3, NCT04975308 / 2021-000079-35: A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

Active, not recruiting

866

Europe, Japan, US, RoW

Imlunestrant, LY3484356, Exemestane, Fulvestrant, Abemaciclib, LY2835219

Eli Lilly and Company, Eli Lilly and Company

Breast Neoplasms, Neoplasm Metastasis

06/24

08/27

EMBER-4, NCT05514054: A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer

Recruiting

6000

Europe, Canada, Japan, US, RoW

Imlunestrant, LY3484356, Tamoxifen, Anastrozole, Letrozole, Exemestane

Eli Lilly and Company

Breast Neoplasms

10/27

03/32

RC48-C006, NCT03500380: A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases

Active, not recruiting

2/3

301

RoW

RC48-ADC, RC48, Lapatinib, Capecitabine

RemeGen Co., Ltd.

Breast Neoplasms, Breast Diseases, Capecitabine, HER2-positive Breast Cancer, HER2 Positive Breast Carcinoma, HER2-positive Advanced Breast With Liver Metastases

07/24

12/24

NCT05744687: Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer

Recruiting

2/3

374

RoW

SPH4336 Tablets 400mg, SPH4336 Tablets Placebo

Shanghai Pharmaceuticals Holding Co., Ltd

Locally Advanced or Metastatic Breast Cancer

05/25

NCT05621434: A Study to Evaluate Inetetamab + Pyrotinib + Chemotherapy in Previously Untreated HER2-Positive Metastatic Breast Cancer

Not yet recruiting

Inetetamab, pyrotinib, chemotherapy, Inetetamab for injection, Pyrotinib maleate

Fujian Medical University

HER2-positive Recurrent/Metastatic Breast Cancer

12/24

12/25

NCT04778839: Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.

Recruiting

RoW

Paclitaxel Micelles for Injection, Paclitaxel injection

First Affiliated Hospital of Zhejiang University, Hangzhou Dihua Biotechnology Co., LTD.

Advanced Solid Tumors

10/24

12/24

NCT04861779: A Study of HSK29116 in Adults With Relapsed/Refractory B-cell Malignancies

Recruiting

156

RoW

HSK29116

Haisco Pharmaceutical Group Co., Ltd.

Relapsed/Refractory B-Cell Malignancies

08/23

10/23

NCT06462326: A Study to Compare the Effect of Omadacycline Versus Moxifloxacin in Healthy Adult Volunteers

Completed

RoW

Moxifloxacin Oral Tablet, Avelox, Omadacycline Oral Tablet, NUZYRA

Zai Lab (Hong Kong), Ltd.

Healthy Volunteer

09/24

KYM901, NCT04805307: Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901

Recruiting

162

RoW

CMG901

Keymed Biosciences Co.Ltd

Advanced Solid Tumor, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Pancreatic Cancer

05/24

10/24

HF1K16-101, NCT05388487: Tolerability and Safety of HF1K16 Injection in Patients With Refractory Solid Tumors

Recruiting

RoW

HF1K16 /Arm 45 mg/m², HF1K16 /Arm 90 mg/m², HF1K16 /Arm 120 mg/m², HF1K16 /Arm 160 mg/m², HF1K16 /Arm 120 mg or 180 mg

HighField Biopharmaceuticals Corporation, Tigermed Consulting Co., Ltd

Solid Tumor, Adult

04/25

11/25

NCT04187469: Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB

Not yet recruiting

N/A

286

RoW

Moxifloxacin, Isoniazid, Rifampicin, Avelox, Myambutol, Nydrazid, Rifampin, Rifadin, Rifampicin,Isoniazid,Pyrazinamide,Ethambutol, Myambutol,Nydrazid,Rifampin,Rifadin

Fifth Affiliated Hospital, Sun Yat-Sen University

Pulmonary Tuberculosis

02/23

02/24

IBBR, NCT03589924: Study to Compare the Safety of Immediate One-stage With Expander-Implant Two-stage Augmented With TiLoop® Bra(COSTA)

Active, not recruiting

N/A

440

RoW

Immediate IBBR+TiLoop®Bra, Immediate-delayed IBBR+TiLoop®Bra

Jiong Wu, First Hospital of China Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, The First Affiliated Hospital with Nanjing Medical University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Breast Cancer

04/23

09/24

MAGIC-MT, NCT04700345: Managing Non-acute Subdural Hematoma Using Liquid Materials：a Chinese Randomized Trial of MMA Treatment

Active, not recruiting

N/A

722

RoW

Onyx, Burr-hole, Medical Management

Huashan Hospital, Shanghai Municipal Health Commission, Shanghai Shen Kang Hospital Development Center

Subdural Hematoma, Non-acute

08/23

06/24

NCT04575207: The Flash FFR Ⅱ Study

Recruiting

N/A

2132

RoW

caFFR, Coronary Angiography-Derived Fractional Flow Reserve, FFR, Fractional Flow Reserve

Peking University First Hospital, Rainmed Ltd., Suzhou, China

Coronary Artery Disease, Coronary Stenosis, Myocardial Ischaemia, Coronary Circulation, Stable Angina Pectoris, Unstable Angina Pectoris, Asymptomatic Ischemia, Acute Myocardial Infarction, Percutaneous Coronary Intervention

12/23

12/25

ZYYY-IIT-TNBC-001, NCT06371274: A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.

Not yet recruiting

N/A

RoW

ATRA, Toripalimab

First Affiliated Hospital of Zhejiang University, Shanghai Longfine Biotechnology Co., Ltd., TopAlliance

Triple-negative Breast Cancer

04/26

NCT05649488: Evaluate the Safety and Efficacy of Intracoronary Lithotripsy Balloon Catheter and Intracoronary Lithotripsy Apparatus

Recruiting

N/A

184

RoW

Intracoronary lithotripsy balloon catheter and Intracoronary lithotripsy apparatus, Dragonfly Opstar Imaging Catheter

Shanghai Bluesail Boyuan Medical Technology Co., Ltd.

Coronary Artery Disease, Intravascular Lithotripsy

12/24

09/25

NCT05760157: Mulltimodal Dynamic Risk Assessment Systems of Heart Failure in Patients With Myocardial Infarction.

Recruiting

N/A

567

RoW

Possible risk factors of heart failure

Jian Liu, Peking University Third Hospital, Beijing Anzhen Hospital, Navy General Hospital, Beijing, Beijing Luhe Hospital, Beijing Chao Yang Hospital

Heart Failure, Acute Myocardial Infarction

12/25

Chen, Gang

NCT04025164: Hypofractionated Vs Conventional Fractionated Radiotherapy After Breast Conserving Surgery

Recruiting

4052

RoW

Hypofractionated Radiotherapy, Experimental Arm, Conventional fractionated Radiotherapy, Standard Arm

Fudan University

Breast Cancer

06/23

06/28

NCT03856372: Hypofractionated Vs Conventional Fractionated Postmastectomy Radiotherapy for High Risk Breast Cancer

Recruiting

1494

RoW

Hypofractionated, Experimental Arm, Conventional, Standard Arm

Fudan University

Breast Cancer

09/23

10/28

SOLARIS, NCT04094688: Vitamin D3 with Chemotherapy and Bevacizumab in Treating Patients with Advanced or Metastatic Colorectal Cancer

Active, not recruiting

455

Bevacizumab, Oxaliplatin, Leucovorin Calcium, Fluorouracil, Irinotecan Hydrochloride, Irinotecan, Cholecalciferol, Vitamin D3, Quality-of-Life Assessment, Questionnaire Administration

Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)

Colorectal Adenocarcinoma

01/26

07/26

METIS, NCT02831959: Pivotal, Open-label, Randomized Study of Radiosurgery with or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases from Non-small Cell Lung Cancer (NSCLC).

Completed

298

Europe, Canada, US, RoW

NovoTTF-200M device, Best Standard of Care

NovoCure GmbH

Brain Metastases from Non-small Cell Lung Cancer (NSCLC)

11/24

NEOPCOSCC, NCT05798793: Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma

Recruiting

309

RoW

Camrelizumab plus TP, SHR-1210 plus Docetaxel, Cisplatin, TP, Docetaxel, Cisplatin

Hospital of Stomatology, Wuhan University, Jiangsu HengRui Medicine Co., Ltd.

Oral Squamous Cell Carcinoma

07/26

10/26

NACI-CERV-003, NCT06288373: Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC

Recruiting

2/3

440

RoW

Camrelizumab, Cisplatin, Nab paclitaxel, Radical surgery, external beam radiation therapy (EBRT) + brachytherapy

Tongji Hospital, Southwest Hospital, China, Women Hospital, School of Medicine, Zhejiang University, Anhui Provincial Cancer Hospital, Sichuan Cancer Hospital and Research Institute, Qilu Hospital of Shandong University, Beijing Friendship Hospital, Tianjin Medical University General Hospital, West China Second University Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Xiangya Hospital of Central South University, Gansu Provincial Maternal and Child Health Care Hospital, Zhejiang Cancer Hospital, Shengjing Hospital, Cancer Hospital of Guangxi Medical University

Cervical Cancer, Locally Advanced Cervical Cancer, Concurrent Chemoradiotherapy, Neoadjuvant Chemoimmunotherapy

03/31

NCT04137107: Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients with Stage II-III Colorectal Cancer

Active, not recruiting

2/3

220

US, RoW

Oxaliplatin, Duloxetine Hydrochloride, Duloxetine, Quality-of-Life Assessment, Questionnaire Administration, Placebo

Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)

Stage II Colorectal Cancer AJCC V8, Stage III Colorectal Cancer AJCC V8

02/26

12/26

COBRA, NCT04068103: Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

Active, not recruiting

2/3

1408

Canada, US

Capecitabine, Ro 09-1978/000, Xeloda, Fluorouracil, 5-Fluoro-2,4(1H, 3H)-pyrimidinedione, 5-Fluorouracil, 5-Fluracil, 5-FU, AccuSite, Carac, Fluoro Uracil, Fluouracil, Flurablastin, Fluracedyl, Fluracil, Fluril, Fluroblastin, Ribofluor, Ro 2-9757, Ro-2-9757, Leucovorin, Folinic acid, Leucovorin Calcium, Adinepar, Calcifolin, Calcium (6S)-Folinate, Calcium Folinate, Calcium Leucovorin, Calfolex, Calinat, Cehafolin, Citofolin, Citrec, citrovorum factor, Cromatonbic Folinico, Dalisol, Disintox, Divical, Ecofol, Emovis, Factor, Citrovorum, Flynoken A, Folaren, Folaxin, FOLI-cell, Foliben, Folidan, Folidar, Folinac, Folinate Calcium, folinic acid, Folinic Acid Calcium Salt Pentahydrate, Folinoral, Folinvit, Foliplus, Folix, Imo, Lederfolat, Lederfolin, Leucosar, leucovorin, Rescufolin, Rescuvolin, Tonofolin, Wellcovorin, Oxaliplatin, 1-OHP, Ai Heng, Aiheng, Dacotin, Dacplat, Diaminocyclohexane Oxalatoplatinum, Eloxatin, Eloxatine, JM-83, Oxalatoplatin, Oxalatoplatinum, RP 54780, RP-54780, SR-96669, Patient Observation, Active Surveillance, deferred therapy, expectant management, observation, Watchful Waiting

NRG Oncology, National Cancer Institute (NCI)

Colon Adenocarcinoma, Stage IIA Colon Cancer AJCC v8

06/23

04/27

CIRCULATE-US, NCT05174169: Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Recruiting

2/3

1912

Canada, US

Signatera test, mFOLFOX6 3-6 month, CAPOX 3 month, mFOLFIRINOX, mFOLFOX6 6 month, CAPOX 6 month

NRG Oncology, Natera, Inc., National Cancer Institute (NCI)

Stage III Colon Cancer

03/29

03/30

NEOPBOSCC, NCT04649476: Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma

Completed

RoW

Camrelizumab, SHR-1210, Camrelizumanb plus TPF, Docetaxel, Cisplatin, 5-Fluorouracil

Hospital of Stomatology, Wuhan University, Jiangsu HengRui Medicine Co., Ltd.

Oral Squamous Cell Carcinoma

08/22

08/24

NACI-CERV-005, NCT06289062: Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer

Recruiting

RoW

Camrelizumab, Cisplatin, Nab paclitaxel, biopsy

Tongji Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Women Hospital, School of Medicine, Zhejiang University, Third Military Medical University, Beijing Friendship Hospital, Sichuan Cancer Hospital and Research Institute, Tianjin Medical University, West China Second University Hospital, Xiangya Hospital of Central South University, Qilu Hospital of Shandong University, Gansu Cancer Hospital, Zhejiang Cancer Hospital, Shengjing Hospital, Anhui Provincial Cancer Hospital

Cervical Cancer, Neoadjuvant Chemoimmunotherapy, Fertility Preservation

12/25

12/30

NCT06289751: Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer

Recruiting

RoW

Cadonilimab, Cadonilimab Injection, AK104, Paclitaxel-albumin, Injectable paclitaxel (albumin bound), Cisplatin, Cisplatin injection, Extrafascial hysterectomy, Radical hysterectomy, Cone biopsy

Tongji Hospital, The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial), Women Hospital, School of Medicine, Zhejiang University, Southwest Hospital, China, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Sichuan Cancer Hospital and Research Institute, Qilu Hospital of Shandong University, Beijing Friendship Hospital, Tianjin Medical University, West China Second University Hospital, Xiangya Hospital of Central South University, Gansu Provincial Maternal and Child Health Care Hospital, Zhejiang Cancer Hospital, Shengjing Hospital

Cervical Cancer, Neoadjuvant Chemoimmunotherapy, Radical Hysterectomy, Extrafascial Hysterectomy

03/26

01/31

NACI-CERV-002, NCT06288360: Neoadjuvant Immunochemotherapy in PD-L1-negative LACC

Recruiting

RoW

Camrelizumab, SHR-1210, Paclitaxel-albumin, Injectable paclitaxel (albumin bound), Cisplatin, Cisplatin injection, radical surgery

Tongji Hospital, Southwest Hospital, China, Women Hospital, School of Medicine, Zhejiang University, Anhui Provincial Cancer Hospital, Sichuan Cancer Hospital and Research Institute, Gansu Provincial Maternal and Child Health Care Hospital, Beijing Friendship Hospital, Tianjin Medical University General Hospital, Xiangya Hospital of Central South University, West China Second University Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Zhejiang Cancer Hospital, Shengjing Hospital, Qilu Hospital of Shandong University, Cancer Hospital of Guangxi Medical University

Cervical Cancer, Locally Advanced Cervical Cancer, PD-L1 Negative, Neoadjuvant Chemoimmunotherapy

12/25

12/30

NCT05892653: A Study of ABM-1310 in Patients With BRAF V600-Mutant Relapsed and Drug Resistant Primary Malignant Brain Tumors

Terminated

RoW

ABM-1310

ABM Therapeutics Shanghai Company Limited

Primary Malignant Brain Tumor

08/24

NCT05339919: Relationship Between Liver Cancer and Sarcopenia

Enrolling by invitation

N/A

1200

RoW

gait speed; ct scan;grip strength and chair stand test

First Affiliated Hospital of Wenzhou Medical University, Qilu Hospital of Shandong University, The Second Hospital of Shandong University

Liver Cancer, Sarcopenia

08/21

08/25

NCT04152967: New Designed ePTFE Valved Conduits for Surgical Reconstruction of Right-ventricular Outflow Tract

Recruiting

N/A

200

RoW

new-designed PTFE valved conduits, Bovine jugular vein valved conduits

Children's Hospital of Fudan University, Shanghai Zhongshan Hospital, Shanghai Children's Medical Center

Right Ventricular Outflow Tract Absent, Congenital Heart Disease, Pulmonary Valve Disorders

12/21

11/22

PINK, NCT06087003: Pediatric Induction Therapy in Kidney Transplantation

Completed

N/A

958

RoW

Basiliximab Injection, Simulect, rabbit ATG, Thymoglobuline

Gang Chen, Zhejiang University, First Affiliated Hospital, Sun Yat-Sen University, The First Affiliated Hospital of Zhengzhou University, Changhai Hospital

Kidney Transplant Rejection, Pediatric Kidney Disease

07/22

09/23

NCT04637048: Observational Study on Patients With Hepatobiliary Tumors

Enrolling by invitation

N/A

1000

RoW

Gang Chen, MD

Hepatocellular Carcinoma, Cholangiocarcinoma, Gallbladder Cancer, Biliary Tract Cancer, Gastric Cancer, Colorectal Cancer

12/23

NCT05543304: Predicting Response to Systemic Therapies for Hepatocellular Carcinoma(HCC)

Enrolling by invitation

N/A

200

RoW

radiological evaluation

First Affiliated Hospital of Wenzhou Medical University, The First Affiliated Hospital of Zhejiang Chinese Medical University, Eastern Hepatobiliary Surgery Hospital, Qilu Hospital of Shandong University

Hepatocellular Carcinoma Non-resectable, Effect of Drug

12/23

12/24

PROBEAT, NCT05179447: PROfiling Based Endometrial Cancer Adjuvant Therapy

Recruiting

N/A

590

RoW

Vaginal brachytherapy, External beam radiotherapy, Observation, Chemoradiation therapy

Women's Hospital School Of Medicine Zhejiang University, Tongji Hospital, Qilu Hospital of Shandong University, Obstetrics & Gynecology Hospital of Fudan University, Sun Yat-sen University, Peking University People's Hospital, Shanghai First Maternity and Infant Hospital, Xiangya Hospital of Central South University, Anhui Provincial Cancer Hospital, Ningbo Women & Children's Hospital, Ningbo No. 1 Hospital

Endometrial Cancer Stage I, Endometrial Cancer Stage II

12/24

01/27

TTV, NCT05727709: Dynamic Changes of Torquetenovirus () Load in Chinese Renal Transplant Recipients

Recruiting

N/A

220

RoW

Tongji Hospital, Anapure BioScience, Caibo MedTech, SKM BioTech

Kidney Transplant Rejection, Kidney Transplant Infection, Virus, Immunosuppression

12/23

06/24

NCT05556434: Predicting Complications of Hepatolithiasis After Hepatectomy

Enrolling by invitation

N/A

500

RoW

radiological evaluation

First Affiliated Hospital of Wenzhou Medical University, Eastern Hepatobiliary Surgery Hospital, The First Affiliated Hospital of Zhejiang Chinese Medical University, Qilu Hospital of Shandong University

Liver Diseases, Complication

07/24

STIPE, NCT04647162: A Clinical Trial About the Safety of Surgical Treatment in Severe Primary Pontine Hemorrhage

Recruiting

N/A

RoW

hematoma evacuation by craniotomy, hematoma evacuation by stereotactic puncture, hematoma evacuation by neuroendoscopy, life support

West China Hospital

Cerebrovascular Disorders, Pontine Hemorrhage, Primary, Surgery

11/24

NCT05480267: A RCT of UBE vs. MIS-TLIF in Lumbar Spondylolisthesis

Not yet recruiting

N/A

340

surgical treatment for lumbar spondylolisthesis

Second Affiliated Hospital, School of Medicine, Zhejiang University, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, RenJi Hospital

Lumbar Spondylolisthesis, Unilateral Biportal Endoscopy, Minimally Invasive Technique, Surgical Treatment

05/25

09/25

NCT05923255: LISH Trial for the Hepatic Flexure and Proximal Transverse Colon Cancer

Recruiting

N/A

568

RoW

LISH （Laparoscopic Ileocecal-Sparing Right Hemicolectomy）, TRH（Traditional Laparoscopic Right Hemicolectomy）

Zhejiang University

Hepatic Flexure Colon Cancer, Proximal Transverse Colon Cancer

05/26

05/31

LUO, Zhiyang

No trials found

LIANG, Yueming

No trials found

HU, Shaozhi

No trials found

ZHANG, Peifang

No trials found

FAN, Yanhua

No trials found



	Diseases Companies Products Productz Mechanisms of Action Sites